Remedy Pharmaceuticals, Inc. Announces Appointment Of Chief Financial Officer

NEW YORK--(BUSINESS WIRE)--Remedy Pharmaceuticals, a clinical stage pharmaceutical company focused on the development and commercialization of a revolutionary, breakthrough drug, CIRARA™, for treating acute central nervous system conditions — where there are inadequate or no approved existing therapies — announced today the appointment of Richard I. Steinhart as Chief Financial Officer effective immediately.